Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Traws Pharma (TRAW) Income from Non-Controlling Interests (2018)

Traws Pharma (TRAW) has disclosed Income from Non-Controlling Interests for 4 consecutive years, with $326000.0 as the latest value for Q3 2018.

  • For Q3 2018, Income from Non-Controlling Interests changed N/A year-over-year to $326000.0; the TTM value through Dec 2018 reached $163000.0, changed N/A, while the annual FY2018 figure was $163000.0, N/A changed from the prior year.
  • Income from Non-Controlling Interests hit $326000.0 in Q3 2018 for Traws Pharma, up from -$163000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $326000.0 in Q3 2018 and bottomed at -$163000.0 in Q2 2018.
  • Average Income from Non-Controlling Interests over 3 years is $750.0, with a median of -$25500.0 recorded in 2014.
  • Year-over-year, Income from Non-Controlling Interests crashed 53.85% in 2014 and then skyrocketed 35.14% in 2015.
  • Traws Pharma's Income from Non-Controlling Interests stood at -$20000.0 in 2014, then changed by 0.0% to -$20000.0 in 2015, then skyrocketed by 1730.0% to $326000.0 in 2018.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $326000.0, -$163000.0, and -$20000.0 for Q3 2018, Q2 2018, and Q2 2015 respectively.